By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) Submits Protocol for Phase II Trial of CF102 in the Treatment of NAFLD/NASH 10/13/2016 6:58:51 AM
Can-Fite BioPharma (CFBI) Reports New Data On CF102's Liver Protective & Regenerative Properties Published In Scientific Journal 9/20/2016 9:04:15 AM
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance For Psoriasis Patent In Europe Ahead Of Phase III Trial 9/13/2016 6:42:17 AM
Can-Fite BioPharma (CFBI) To Present At Rodman & Renshaw Conference In New York City On September 12, 2016 9/7/2016 10:41:02 AM
Can-Fite BioPharma (CFBI) Reports Financial Results For Six Months Ended June 30, 2016 8/26/2016 9:55:19 AM
Can-Fite BioPharma (CFBI)'s Phase II/III Psoriasis Study Results Published In Journal Of Drugs In Dermatology 8/8/2016 7:53:23 AM
Can-Fite BioPharma (CFBI) Completes Phase II Study Design For CF102 In The Treatment Of NASH/NAFLD 7/25/2016 6:08:29 AM
Can-Fite BioPharma (CFBI) Reports New Data Showing Its Psoriasis Drug May Offer Efficacy Similar To Industry Leading Biologics Without Harmful Side Effects 6/16/2016 11:36:21 AM
Can-Fite BioPharma (CFBI) Submits Psoriasis Phase III Protocol And Registration Plan To European Medicines Agency For Piclidenoson (CF101) 6/7/2016 8:04:04 AM
BIO2016: Can-Fite BioPharma (CFBI) To Exhibit At Bio International Convention In San Francisco On June 6-9, 2016 6/6/2016 12:36:50 PM